Business

Mass. movers

Cerulean drug shows antitumor potential

The Cerulean drug is used to treat ovarian cancer.

Associated Press/File 2014

The Cerulean drug is used to treat ovarian cancer.

Advertisement

Cerulean Pharma Inc., of Cambridge, announced that its CRLX101, a proprietary investigational drug, exhibits powerful antitumor properties, according to preclinical data. The drug was potent alone as well as in combination with Avastin, a Genentech Inc. cancer drug. “The combination of CRLX101 and Avastin is synergistic, with the potential to enhance survival of patients with ovarian cancer,” said Robert S. Kerbel, a researcher on the manuscript of data released Tuesday.

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.